Eisai Co., Ltd. (ESAIY)
7.65
-0.01
(-0.13%)
USD |
OTCM |
Sep 15, 16:00
Eisai Enterprise Value : 8.558B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 8.558B |
| September 14, 2026 | 8.570B |
| September 11, 2026 | 8.445B |
| September 10, 2026 | 8.355B |
| September 09, 2026 | 8.332B |
| September 08, 2026 | 8.361B |
| September 04, 2026 | 8.355B |
| September 03, 2026 | 8.581B |
| September 02, 2026 | 8.315B |
| September 01, 2026 | 8.208B |
| August 31, 2026 | 8.242B |
| August 28, 2026 | 8.344B |
| August 27, 2026 | 8.390B |
| August 26, 2026 | 8.399B |
| August 25, 2026 | 8.547B |
| August 24, 2026 | 8.479B |
| August 21, 2026 | 8.694B |
| August 20, 2026 | 8.615B |
| August 19, 2026 | 8.671B |
| August 18, 2026 | 8.355B |
| August 17, 2026 | 8.276B |
| August 14, 2026 | 8.476B |
| August 13, 2026 | 8.502B |
| August 12, 2026 | 8.721B |
| August 11, 2026 | 8.694B |
| Date | Value |
|---|---|
| August 10, 2026 | 8.660B |
| August 07, 2026 | 8.457B |
| August 06, 2026 | 8.163B |
| August 05, 2026 | 7.960B |
| August 04, 2026 | 8.197B |
| August 03, 2026 | 8.106B |
| July 31, 2026 | 8.344B |
| July 30, 2026 | 8.784B |
| July 29, 2026 | 8.671B |
| July 28, 2026 | 8.186B |
| July 27, 2026 | 8.061B |
| July 24, 2026 | 7.937B |
| July 23, 2026 | 7.756B |
| July 22, 2026 | 7.745B |
| July 21, 2026 | 7.688B |
| July 20, 2026 | 7.598B |
| July 17, 2026 | 7.632B |
| July 16, 2026 | 7.485B |
| July 15, 2026 | 7.282B |
| July 14, 2026 | 7.462B |
| July 13, 2026 | 7.485B |
| July 10, 2026 | 7.406B |
| July 09, 2026 | 7.338B |
| July 08, 2026 | 7.349B |
| July 07, 2026 | 7.349B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 86.67B |
| Daiichi Sankyo Co., Ltd. | 32.45B |
| Chugai Pharmaceutical Co., Ltd. | 62.57B |
| Santen Pharmaceutical Co., Ltd. | 3.291B |
| Ono Pharmaceutical Co., Ltd. | 6.445B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 120.18M |
| Revenue (Quarterly) | 1.471B |
| Total Expenses (Quarterly) | 1.356B |
| EPS Diluted (Quarterly) | 0.1015 |
| Gross Profit Margin (Quarterly) | 78.20% |
| Profit Margin (Quarterly) | 8.17% |
| Earnings Yield | 3.18% |
| Operating Earnings Yield | 3.28% |
| Normalized Earnings Yield | 3.176 |